Capriotti Kara, Stewart Kevin, Pelletier Jesse, Capriotti Joseph
Veloce BioPharma LLC;; Bryn Mawr Skin and Cancer Institute.
Veloce BioPharma LLC;; Plessen Ophthalmology Consultants.
J Clin Aesthet Dermatol. 2017 Mar;10(3):41-45. Epub 2017 Mar 1.
To report our experience using a broad spectrum antimicrobial, povidone-iodine, as a novel at-home prescription treatment for molluscum contagiosum. A systematic review of cases presenting to one of the author's private dermatology clinics from January to July of 2015 identified 12 patients with molluscum contagiosum seeking treatment. The population was pediatric, with six males and six female patients included (age range 2-17 years, mean age 6 years). Patients were evaluated at baseline and returned to the office for evaluation at four-week intervals until resolution or failure to show for appointments, with number and location of lesions being recorded at each visit. Adverse effects were evaluated at each visit. All 12/12 (100%) patients demonstrated complete or partial resolution. There were a total of 115 lesions treated in the case series, and 103/115 (90%) resolved. Complete resolution occurred in 8/12 (67%) patients. Of the 8/12 with complete resolution, 4/8 (50%) patients showed complete resolution at the four-week follow-up visit and 4/8 (50%) showed complete resolution at the eight-week follow-up. Of the 4/12 (33%) patients who failed to demonstrate complete resolution, 4/4 (100%) showed partial resolution. This case series demonstrates considerable success for treatment of molluscum contagiosum with a dilute povidone-iodine preparation. The treatment was well-tolerated, with minimal side effects.
报告我们使用广谱抗菌剂聚维酮碘作为传染性软疣新型家庭处方治疗方法的经验。对2015年1月至7月在作者之一的私人皮肤科诊所就诊的病例进行系统回顾,确定了12例寻求治疗的传染性软疣患者。患者均为儿童,包括6名男性和6名女性(年龄范围2至17岁,平均年龄6岁)。患者在基线时接受评估,并每隔四周返回诊所进行评估,直至痊愈或未按预约前来就诊,每次就诊时记录皮损的数量和位置。每次就诊时评估不良反应。所有12/12(100%)患者均表现出完全或部分消退。该病例系列共治疗了115处皮损,其中103/115(90%)消退。8/12(67%)患者实现完全消退。在8例完全消退的患者中,4/8(50%)患者在四周随访时完全消退,4/8(50%)患者在八周随访时完全消退。在4/12(33%)未实现完全消退的患者中,4/4(100%)表现出部分消退。该病例系列表明,用稀释的聚维酮碘制剂治疗传染性软疣取得了相当大的成功。该治疗耐受性良好,副作用极小。